Cambios longitudinales en el índice de ROX y el puntaje de HACOR en pacientes críticos con insuficiencia respiratoria aguda por COVID-19 que requirieron cánula nasal de alto flujo: estudio de cohorte retrospectivo
| datacite.rights | http://purl.org/coar/access_right/c_f1cf | |
| dc.contributor.advisor | Rojas Suarez, José Antonio | |
| dc.contributor.advisor | Dueñas Castell, Carmelo | |
| dc.contributor.author | Diaz Ramírez, Helman Alfonso | |
| dc.contributor.author | Sallas Rodriguez, Izeth Mercedes | |
| dc.date | 30/12/2050 | |
| dc.date.accessioned | 2024-06-14T23:11:38Z | |
| dc.date.available | 2024-06-14T23:11:38Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Introducción: Durante la pandemia de SARS-CoV-2, emergió la necesidad de validar el uso de la Cánula Nasal de Alto Flujo (CNAF) y sus indicadores de éxito en pacientes con Infecciones Respiratorias Agudas Graves (IRAG). Objetivo: evaluar el impacto clínico del uso de la cánula nasal de alto flujo (CNAF) en pacientes con insuficiencia respiratoria aguda hipoxémica moderada a severa debido a SARS CoV-2, y validar la efectividad de los índices IROX, HACOR score en dos tiempos críticos: al inicio del tratamiento y a las 24 horas, así como el delta de estos índices. Materiales y métodos: Un estudio de cohorte retrospectivo. Se llevó a cabo en la unidad de cuidados intensivos de una IPS en Cartagena, Colombia. Se incluyeron en el estudio aquellos que cumplieron con los siguientes criterios de inclusión. Del total de las historias revisadas, se excluyeron 41 de ellas porque no cumplían con los criterios de inclusión. Finalmente, se analizaron un total de 115 pacientes. La presente investigación es diseñada cumpliendo con los lineamientos éticos establecidos en los documentos internacional y nacionalmente aceptados. Se realizó un estudio retrospectivo con 115 pacientes, analizando el uso de CNAF y evaluando estas herramientas y el delta al inicio y a las 24 horas de su uso. | spa |
| dc.description.abstract | Introduction: During the SARS-CoV-2 pandemic, the need emerged to validate the use of the High Flow Nasal Cannula (HFNC) and its success indicators in patients with Severe Acute Respiratory Infections (SARI). Objective: Our main objective was to evaluate the clinical impact of the use of highflow nasal cannula (HFNC) in patients with moderate to severe hypoxemic acute respiratory failure due to SARSCoV- 2, and to validate the effectiveness of the IROX, HACOR indices score at two critical times: at the beginning of treatment and at 24 hours as well as the delta of these indices. Materials and methods: A retrospective cohort study. It was carried out in the intensive care unit of an-IPS in Cartagena, Colombia. Those who met the following inclusion criteria were included in the study. Of the total stories reviewed, 41 were excluded because they did not meet the inclusion criteria. Finally, a total of 115 patients were analyzed. This research is designed in compliance with the ethical guidelines established in internationally and nationally accepted documents. A retrospective study was carried out with 115 patients, analyzing the use of HFNC and evaluating these tools and the delta at the beginning and 24 hours after their use. | eng |
| dc.format.mimetype | ||
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/14738 | |
| dc.language.iso | spa | |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | eng |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | eng |
| dc.rights.accessrights | info:eu-repo/semantics/embargoedAccess | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
| dc.subject | Cánula nasal de alto flujo | spa |
| dc.subject | SARS-CoV-2 | spa |
| dc.subject | Ventilación no invasiva | spa |
| dc.subject | Insuficiencia Respiratoria Hipoxémica Aguda | spa |
| dc.subject.keywords | High flow nasal cannula | eng |
| dc.subject.keywords | Non-invasive ventilation | eng |
| dc.subject.keywords | Acute Hypoxemic Respiratory Failure | eng |
| dc.title | Cambios longitudinales en el índice de ROX y el puntaje de HACOR en pacientes críticos con insuficiencia respiratoria aguda por COVID-19 que requirieron cánula nasal de alto flujo: estudio de cohorte retrospectivo | spa |
| dc.type.driver | info:eu-repo/semantics/other | |
| dc.type.spa | Otros | |
| dcterms.references | Grieco DL, Maggiore SM, Roca O, Spinelli E, Patel BK, Thille AW, et al. Noninvasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47:851– 66. Disponible en: https://doi.org/10.1007/s00134-021-06459-2 | eng |
| dcterms.references | Montiel V, Robert A, Robert A, Nabaoui A, Marie T, Mestre NM, et al. Surgical mask on top of high-flow nasal cannula improves oxygenation in critically ill COVID-19 patients with hypoxemic respiratory failure. Ann Intensive Care. 2020; 10:125. Disponible en: https://doi.org/10.1186/s13613-020-00744-x | eng |
| dcterms.references | Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ, et al. A New Global Definition of Acute Respiratory Distress Syndrome. In: American Journal of Respiratory and Critical Care Medicine. American Thoracic Society; 2024. p. 37–47. | eng |
| dcterms.references | Reilly JP, Calfee CS, Christie JD. Acute Respiratory Distress Syndrome Phenotypes. Respir Crit Care Med. 2019;40:19–30 Disponible en: https://doi.org/ | eng |
| dcterms.references | Organización Panamericana de la Salud. Cronología de la respuesta de la OMS a la COVID-19. 2021 [citado 2021 Nov 7]. Disponible en: https://www.who.int/es/news/item/29-06-2020-covidtimeline | spa |
| dcterms.references | Organización Panamericana de la Salud. Brote de enfermedad por el Coronavirus (COVID-19). [citado 2021 Nov 7]. Disponible en: 57 https://www.paho.org/es/temas/coronavirus/brote-enfermedad-por-coronaviruscovid- 19 | spa |
| dcterms.references | Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Vol. 41, Trends in Immunology. Elsevier Ltd; 2020. p. 1100–15. | eng |
| dcterms.references | Chica-Meza C, Peña-López LA, Villamarín-Guerrero HF, Moreno-Collazos JE, Rodríguez-Corredor LC, Lozano WM, et al. Respiratory care in Covid-19. Vol. 20, Acta Colombiana de Cuidado Intensivo. Elsevier Doyma; 2020. p. 108–17. | spa |
| dcterms.references | Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S, Frat JP, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019 May 1; 45(5):563–72. Disponible en: https://link.springer.com/article/10.1007/s00134-019-05590-5 | eng |
| dcterms.references | Roca O, Li J, Mauri T. High-flow nasal cannula: evolving practices and novel clinical and physiological insights Latest advances in understanding the physiological effects of high-flow nasal cannula. Intensive Care Med. 2024 ;50:758–61. Disponible en: https://doi.org/10.1007/s00134-024-07386-8 | eng |
| dcterms.references | Mellado-Artigas R, Ferreyro BL, Angriman F, Hernández-Sanz M, Arruti E, Torres A, et al. Prolonged prone position ventilation for SARS-CoV-2 patients is feasible and effective. 2020; Disponible en: https://doi.org/10.1186/s13054-021-03469-w | eng |
| dcterms.references | Ospina-Tascón GA, Calderón-Tapia LE, García AF, Zarama V, Gómez-Álvarez F, Álvarez-Saa T, et al. Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With 58 Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Dec 7; 326(21):2161–71. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2786830 | eng |
| dcterms.references | Magdy D, Metwally A. La utilidad de la puntuación HACOR para predecir la falla del oxígeno nasal de alto flujo en la insuficiencia respiratoria hipoxémica aguda. | spa |
| dcterms.references | Fernando Valencia C, Lucero OD, Casas Castro O, Sanko AA, Peter &, Olejua A. Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia. Scientific Reports |. 123AD; 11:22559. Disponible en: www.nature.com/scientificreports | eng |
| dcterms.references | Mannarino MR, Bianconi V, Cosentini E, Figorilli F, Natali C, Cellini G, et al. The HACOR Score Predicts Worse in-Hospital Prognosis in Patients Hospitalized with COVID-19. J Clin Med. 2022 Jun 1;11(12). | eng |
| dcterms.references | Medeiros KJ, Valsecchi C, Winterton D, Morais CA, Delgado ED, Smith S, et al. A Prospective Observational Study on Short and Long-Term Outcomes of COVID-19 Patients with Acute Hypoxic Respiratory Failure Treated with High-Flow Nasal Cannula. J Clin Med. 2023 Feb 1;12(4). | eng |
| dcterms.references | Vega M, Dongilli R, Olaizola G, Colaianni N, Sayat M, Pisani L, et al. COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Authors’ reply. Pulmonology. 2021;27:475–6. Disponible en: https://doi.org/10.1016/j. | eng |
| dcterms.references | Prakash J, Bhattacharya PK, Yadav AK, Kumar A, Tudu LC, Prasad K. ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with 59 acute hypoxemic respiratory failure: A systematic review and meta-analysis. J Crit Care. 2021 Dec 1;66:102–8. | eng |
| dcterms.references | Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92. | eng |
| dcterms.references | Lai CKC, Lam W. Laboratory testing for the diagnosis of COVID-19. Biochem Biophys Res Commun. 2021 Jan 29;538:226–30. | eng |
| dcterms.references | Weerakkody S, Arina P, Glenister J, Cottrell S, Boscaini-Gilroy G, Singer M, et al. Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research. Lancet Respir Med. 2022 Feb 1;10(2):199–213. Disponible en: http://www.thelancet.com/article/S2213260021004148/fulltext | eng |
| dcterms.references | Ward JJ. High-flow oxygen administration by nasal cannula for adult and perinatal patients. In: Respiratory Care. 2013. p. 98–120. | eng |
| dcterms.references | Slobod D, Spinelli E, Crotti S, Lissoni A, Galazzi A, Grasselli G, et al. Effects of an asymmetrical high flow nasal cannula interface in hypoxemic patients. Crit Care. 2023 Dec 1;27(1). | eng |
| dcterms.references | Rodriguez M, Thille AW, Boissier F, Veinstein A, Chatellier D, Robert R, et al. Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter study. Ann Intensive Care. 2019; 9:101. Disponible en: https://doi.org/10.1186/s13613-019-0578-8 | eng |
| dcterms.references | Celemín CA, Jiménez JK, Riscanevo N, de Ferrater AT, Moscoso A, Chaustre JE, et al. Clinical outcomes in patients with a diagnosis of pneumonia related to SARSCoV- 2 managed with a high-flow cannula, a clinical experience. (CANALF study). Acta Colombiana de Cuidado Intensivo. 2022 Jun 1;22:S1–10. | eng |
| dcterms.references | Hancı P, Uysal A, Yüksel B, İnal V. Rox Index Dynamics According to High Flow Nasal Cannula Success in Intensive Care Unit Patients with COVID-19-Related Acute Respiratory Failure. Balkan Med J. 2023; 40:111–6. Disponible en: www.balkanmedicaljournal.org | eng |
| dcterms.references | Smesseim I, Mooij-Kalverda K, Hessels L, Korevaar DA, Atasever | Burak, Hjalmar De Graaff |, et al. High flow nasal cannula for acute respiratory failure due to COVID-19 in patients with a “do-not-intubate” order: A survival analysis. Clin Respir J. 2023; Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/crj.13573 | eng |
| dcterms.references | Weerakkody S, Arina P, Glenister J, Cottrell S, Boscaini-Gilroy G, Singer M, et al. Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research. Vol. 10, The Lancet Respiratory Medicine. Elsevier Ltd; 2022. p. 199–213. | eng |
| dcterms.references | Aroca G, Depine S, Vélez M, Dianda D, Gómez L, Cueto M, et al. Monitorización, evolución y pronostico en pacientes con enfermedad renal en hemodialisis con infeccion severa por sars-cov 2. Disponible en: https://www.actamedicacolombiana.com/ojs/index.php/actamed/article/view/2696/ 1837 | spa |
| dcterms.references | Duan J, Chen L, Liu X, Bozbay S, Liu Y, Wang K, et al. An updated HACOR score for predicting the failure of noninvasive ventilation: a multicenter prospective observational study. 2020; Disponible en: https://doi.org/10.1186/s13054-022- 04060-7 | eng |
| dcterms.references | Abroug F, Hammouda Z, Lahmar M, Nouira W, Maatouk S, Youssef S, et al. High- Flow Nasal Cannula and Prone Positioning in Awake Patients with COVID-19 Related Respiratory Failure: An Observational Study. Res Sq. | eng |
| dcterms.references | Linfu B, Fei D, Weiming X, Weiwei S, Lei J, Yuliang L, et al. Early assessment of the efficacy of noninvasive ventilation tested by HACOR score to avoid delayed intubation in patients with moderate to severe ARDS. Ther Adv Respir Dis. Disponible en: https://doi.org/10.1177/17534666221081042https://doi.org/10.1177/17534666221 081042 | eng |
| dcterms.references | Basoulis D, Avramopoulos P, Aggelara M, Karamanakos G, Voutsinas PM, Karapanou A, et al. Validation of Sequential ROX-Index Score beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula. Can Respir J. 2023;2023. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | |
| sb.programa | Especialización en Medicina Crítica y Cuidados Intensivos | spa |
| sb.sede | Sede Barranquilla | spa |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 2.93 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: